Tofacitinib for the treatment of severe rare skin diseases: a narrative review Fenglin LuoYuanyuan ZhangPing Wang Review 17 January 2024 Pages: 481 - 492
Remimazolam versus propofol for sedation in gastrointestinal endoscopy and colonoscopy within elderly patients: a meta-analysis of randomized controlled trials Wania AhmerSahar ImtiazMuhammad Omar Larik Review 23 January 2024 Pages: 493 - 503
Feasibility and safety of EGFR-TKI neoadjuvant therapy for EGFR-mutated NSCLC: A meta-analysis Zhuchen YuFei XuJuntao Zou Review 01 February 2024 Pages: 505 - 517
The lack of head-to-head randomised trials and the consequences for patients and national health service: The case of non-small cell lung cancer Ruggero LasalaAlessia RomagnoliFelice Musicco Research 20 January 2024 Pages: 519 - 527
Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation Shampa DasTodd RiccobeneSusan Raber Research Open access 22 January 2024 Pages: 529 - 543
Cardiovascular medications used for comorbid diseases in patients with atrial fibrillation. The JoFib study Nasr AlrabadiMohammed Al-NusairAyman Hamoudeh Research 23 January 2024 Pages: 545 - 552
Patterns of inappropriate prescribing and clinical characteristics in patients at admission to an acute care of the elderly unit Mónica ZuletaAntonio San-JoséCarmen Pérez-Bocanegra Research 24 January 2024 Pages: 553 - 561
The relationship between use of SGLT2is and incidence of respiratory and infectious diseases and site-specific fractures: a meta-analysis based on 32 large RCTs Yueping WangXian Zhou Research 25 January 2024 Pages: 563 - 573
Estimating the impact of label design on reducing the risk of medication errors by applying HEART in drug administration Carlos Aceves-GonzalezAngela Caro-RojasKaren Hernández-Cruz Research Open access 29 January 2024 Pages: 575 - 588
Dabigatran-related serious medication errors: an analysis using data from VigiBase Qingxia ZhangQian DingQun-Ying Yue Research Open access 29 January 2024 Pages: 589 - 595
Association of the predicted free blood concentration of teicoplanin with the development of renal dysfunction Kyohei SugiyamaKeita HiraiKenta Ito Research 29 January 2024 Pages: 597 - 602
Comparing AGS Beers 2019, STOPP version 2, and EU(7)-PIM list in Portuguese older adults in primary health care Daniela A. RodriguesMaria Teresa HerdeiroFátima Roque Research Open access 06 February 2024 Pages: 603 - 612
Association of SGLT2 inhibitor dapagliflozin with risks of acute kidney injury and all-cause mortality in acute myocardial infarction patients Dabei CaiQianwen ChenLing Sun Research Open access 06 February 2024 Pages: 613 - 620
Comment on “Risk of gastric cancer among long‑term proton pump inhibitor users: a population‑based cohort study” Shih-Wei LaiBing-Fang HwangKuan-Fu Liao Correspondence 31 January 2024 Pages: 621 - 622
Retraction Note: Graphical representation of network meta-analysis: an iconographic support to the complexity of multiple data comparisons Renato De VecchisCarmelina ArianoMichel Noutsias Retraction Note 10 February 2024 Pages: 623 - 623